This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Bowel obstruction is a medical condition where the normal passage of digestive waste through the intestines is blocked. This can be caused by a physical blockage, such as a tumor, or by an accumulation of fecal matter in the bowels. In either case, it can cause severe abdominal pain, nausea, vomiting, and dehydration. If left untreated, it can lead to an infection or even death. The most common causes of bowel obstruction are hernias, tumors, or strictures. Hernias are caused when a portion of the intestines or stomach bulges out of its normal location, causing a physical blockage. Tumors can cause obstruction by forming a physical blockage or by blocking off the normal flow of digestive material. Strictures are a narrowing of the intestines, which can also cause a blockage. Once a diagnosis of bowel obstruction has been made, treatment will depend on the cause. Surgery is often necessary to remove the blockage, and medications may be prescribed to help relieve the symptoms. In some cases, a tube may be inserted into the intestine to allow the passage of fluid and gas. If an infection is present, antibiotics may be prescribed. Once the blockage has been removed, it is important to make lifestyle changes to help prevent it from recurring. This can include making dietary changes, such as eating smaller meals more frequently and avoiding high-fiber foods. It is also important to get regular exercise to help promote healthy digestion. Finally, staying hydrated is key in preventing future blockages.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States